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Abstract This study investigated the performance of the
portable Cortex Metamax 3B (MM3B) automated gas
analysis system during both simulated and human exercise
using adolescents. Repeated measures using a Gas Exchange
System Validator (GESV) across a range of simulated met-
abolic rates, showed the MM3B to be adequately reliable
(both percentage errors, and percentage technical error of
measurements\2%) for measuring expired ventilation (VE),
oxygen consumption (VO2), and carbon dioxide production
(VCO2). Over a 3 h period, the MM3B was shown to be
acceptably stable in measuring gas fractions, as well as VE,
VO2, and VCO2 generated by the GESV, especially at
moderate and high metabolic rates (drifts\2% and of minor
physiological significance). Using eight healthy adolescents
during rest, moderate, and vigorous cycle ergometry, the
validity of the MM3B was tested against the primary crite-
rion Douglas bag method (DBM) and a secondary criterion
machine known to be accurate, the Jaeger Oxycon Pro sys-
tem. No significant errors in VE were noted, yet the MM3B
significantly overestimated both VO2 and VCO2 by approx-
imately 10–17% at moderate and vigorous exercise as
compared to the DBM and at all exercise levels compared to
the Oxycon Pro. No significant differences were seen in any
metabolic variable between the two criterion systems (DBM
and Oxycon Pro). It is concluded the MM3B produces
acceptably stable and reliable results, but is not adequately
valid during moderate and vigorous exercise without some
further correction of VO2 and VCO2.
Keywords Validity  Reliability  Stability  Metamax 
Portable gas analysis
Introduction
The measurement of oxygen uptake (VO2) and its associated
variables, carbon dioxide production (VCO2) and expired
ventilation (VE), are now commonly performed in many lab-
oratories around the world in order to assess cardiorespiratory
fitness and the metabolic demands of various activities. Tra-
ditionally these measurements were undertaken in controlled
laboratory conditions via open-circuit calorimetry using
developments of the original Douglas bag method (DBM)
(Douglas 1911). The advent of automated computerized
metabolic gas analysis systems has generally overtaken the
time-consuming and skill-dependent DBM in most labs
(Macfarlane 2001). The DBM can be used in field trials
(Daniels 1971), but it remains very limited due to its bulk,
added air-resistance, and inability to easily undertake
sequential measurements (Durnin and Passmore 1967). Con-
sequently, a number of portable systems have been designed
to acquire metabolic gas measurements during field studies.
One of the earliest portable systems was the fully
mechanical Max-Planck respirometer, developed during
the Second World War and often referred to as the Kofr-
anyi–Michaelis respirometer (Johnson et al. 1967) after the
authors of an early publication (Kofranyi and Michaelis
1949). The early automated portable systems (e.g., ‘‘Oxy-
con’’, ‘‘Oxylog’’ and ‘‘K2’’) were restricted to only the
measurement of VE and VO2 (not VCO2) (Macfarlane
2001). Modern technologies now permit portable systems
weighing less than 2 kg to possess virtually all the data
collection powers of their lab-based counterparts (often
recording or telemetering breath-by-breath and heart rate
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data). One such system is the Metamax 3B (MM3B) sys-
tem (Cortex, Leipzig, Germany), that is also marketed as
the VmaxST in many countries, which supersedes the
earlier Metamax I and II models that were shown to be
valid and reliable (Medbo et al. 2002).
To be able to be used in discipline-specific field studies,
these portable gas analysis systems have to be not only small
and unobtrusive, but also reliable and valid. There is a lack of
consensus on not only the level of precision and accuracy
expected for measures of VO2 and VE (Macfarlane 2001), but
also which method is most appropriate to assess both reli-
ability and validity. For example, studies have reported the
reliability of the MM3B by comparing data acquired from
human participants twice on different days (Perkins et al.
2004), yet this analysis will include not only the technical
error but also the biological within-subject variation. Only
reliability comparisons of dual measurements using a gas
exchange simulator will remove the within-subject variation,
and this has been reported recently with the MM3B (Vogler
et al. 2010). Three validation studies on the MM3B have
been performed against the DBM (Brehm et al. 2004; Prieur
et al. 2003; Vogler et al. 2010), and despite its limitations the
DBM is often considered to be the criterion (Hodges et al.
2005), especially when precise metabolic calibrators are not
available (Gore et al. 1997). Yet other validation studies on
the MM3B have only used a previously validated automated
system as its criterion measure (Laurent et al. 2008; Perkins
et al. 2004), a method that has been questioned as not being a
true gold standard (Meyer et al. 2005). Ideally, any metabolic
gas analysis system, such as the MM3B, should have its
reliability reported using a gas exchange simulator and its
validity reported compared to at least the DBM. Only one
extensive study has published such data on the MM3B
(Vogler et al. 2010); however, this study focused on elite
athletes at relatively high levels of performance and did not
include resting or light activity. In order to determine if the
MM3B could be applied to the common non-elite popula-
tions such as children, validity and reliability trials were
needed at much lower physiological levels.
Furthermore, it is important for any metabolic gas
analysis system to also demonstrate that, once calibrated, it
does not drift significantly (i.e., is stable) over the usual
data-acquisition period. For measurements taken in or near
a laboratory this may only require determining the stability
over a 20 min period (Prieur et al. 2003), but for some
studies, the calibration of a portable system in the field may
be problematic due to the need for carrying bulky cali-
bration equipment, including large pressurized bottles of
alpha-standard calibration gases. Thus, some portable
systems may need to be initially calibrated in a laboratory
and then transported and used at a significant time later for
field studies. The identification of how each gas analyzer
and resultant VO2 and VCO2 drifts in these situations is
rarely reported (Atkinson et al. 2005). Only one study has
reported on the stability of the Cortex Metamax 3B/
VmaxST system, but this was for only a maximum of
20 min (Prieur et al. 2003) and many field studies may
exceed this duration. Furthermore, it is important to match
the type of validation as to how the testing system will be
used (Unnithan et al. 1994), and although many automated
metabolic systems are used on pediatric/adolescent popu-
lations, few systems have been actually validated using
these groups (Unnithan et al. 1994).
The aim of this study was therefore to report on the
suitability of the MM3B to measure variables over non-
elite physiological ranges, especially those commonly
found in pediatric/adolescent or elderly groups, as well as
its ability to be used in prolonged field situations. We
therefore studied the performance of the MM3B system
for (1) reliability, using a commercially available gas
exchange simulator; (2) stability/drift over a 3 h period; (3)
validity, compared to both the criterion DBM as well as a
previously validated gas analysis system (Jaeger Oxycon
Pro) using an adolescent sample.
Methods
Participants
Eight healthy young volunteers (3 boys, 5 girls) were
recruited with the following characteristics (mean ± SD):
age 12.9 ± 3.6 years; height 150.1 ± 13.1 cm; mass
44.6 ± 11.5 kg. All subjects, as well as their legal guard-
ians, provided a written informed consent after the project
was approved by the Research Ethics Committee of the
University of Hong Kong.
Equipment
Metamax 3B (breath-by-breath system)
The MM3B is a portable metabolic system composed of a
measurement module and a battery module. These two
parts are of the same size (120 9 110 9 45 mm) and
designed to be worn on the chest with a harness, with a
total weight of 1.40 kg. The MM3B measures volume
using a bidirectional digital turbine. A 60 cm length of
Nafion/Permapure sampling tube is attached to the turbine
to permit analysis of the O2 and CO2 concentrations using
an electrochemical cell and an infrared analyzer, respec-
tively. VO2 and VCO2 were calculated using standard
metabolic algorithms (Wasserman et al. 1999) employing
the Haldane transformation, but with FIO2 and FICO2
continuously measured, rather than assumed to be constant,
in order to correct for changes in ambient conditions.
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The breath-by-breath data of respiratory volume and gas
concentrations can be stored in on-board memory for later
downloading to a PC, or sent immediately via telemetry to
a PC. The system was tested using Metasoft 3 software,
version 3.7.0 SR2.
Prior to using, the system was turned on for at least
20 min, and then calibrated prior to every test according to
the manufacturer’s recommendations. This involves first
calibrating the gas analysers by using a reference gas
(14.97% O2, 4.96% CO2, balance N2: ±0.02% absolute,
Hong Kong Specialty Gases), and then verifying the cali-
bration against ambient air. Secondly, a volume calibration
was performed using a standardized 3-L syringe (5530
series, Hans Rudolph, Inc., MO, USA). For avoiding
potential gas leakages known to be problematic with
facemasks, all participants wore a nose clip and had a
mouthpiece attached to the MM3B turbine.
Gas Exchange System Validator (GESV)
The GESV (MedGraphics, MA, USA; a similar, but
updated, GESV is now sold by Vacumed, CA, USA) was a
mechanical gas exchange system simulating human
breathing and has a reported accuracy in producing VO2
and VCO2 of ±2% (Huszczuk et al. 1990). When a gas of
known CO2 concentration (recommended 21.00%) was
added to the inspirate, the GESV expired gas of constant
expired fractions at ambient temperature and pressure that
could be used to simulate a range of VO2 and VCO2. The
GESV could be adjusted so that it simulated breathing over
a wide range of tidal volumes (0.5, 1.0, 1.5, 2.0, 2.5 and
3.0 L) at various respiratory rates (low = 10 breaths
min-1; medium = 20 breaths min-1; and high = 40
breaths min-1). These resulted in minute ventilations
ranging from 5 to 104 L min-1; VO2 ranging from 0.30 to
2.81 L min-1; and VCO2 ranging from 0.29 to
2.69 L min-1.
Douglas bag method (DBM)
With each participant wearing a nose clip and mouthpiece
attached to a Radiax valve (dead space *28 ml), all
expired gases were collected in 250 L Douglas bags (WE
Collins, Braintree, USA) using a 1 m length of Collins
spiral tubing (38 mm ID) and a Collins 3-way stopcock.
The mixed expirates were analyzed within 15 min using an
S-3A oxygen and CD-3A carbon dioxide analyzer (Applied
Electrochemistry, Sunnyvale, CA: now AEI Technologies)
that had been previously calibrated using two alpha/pri-
mary-reference gases (26.13% O2 and 0.00% CO2; 13.94%
O2 and 5.96% CO2; all gases ±0.02% absolute, Hong Kong
Specialty Gases) and checked against ambient air (analyser
linearity was checked using 0.00, 13.94 and 26.13% O2,
and 0.00, 4.96 and 5.96% CO2 as well as ambient air). The
volume of the Douglas bag was measured by a dry gas
meter (Harvard, USA), with the aid of a vacuum pump on
the exit port. The temperature of the expired gas was
monitored with a telethermometer (YSI, Ohio, USA)
placed at the outlet of the gas meter for later correction to
‘‘standard temperature pressure dry’’ (STPD), and ‘‘body
temperature pressure saturated’’ (BTPS). All bags were
checked for an absence of leaks and diffusion (no change in
volume or composition of mixed expirate noted over a
30 min period), and each one flushed with expired gases
before use to reduce the dilution effect of dead-space gas
trapped in the bag and any rigid tubing.
Jaeger Oxycon Pro
The Oxycon Pro (Jaeger—now CareFusion, Germany;
running JLab Software version 4.66.0) was used in its
‘‘mixing-chamber mode’’ with participants, wearing a nose
clip, breathing via a mouthpiece and Radiax valve. The
system was turned on for at least 30 min prior to use, and
then fully calibrated for gases (14.00% O2, 6.00% CO2:
±0.02% absolute, Hong Kong Specialty Gases) and vol-
umes before every test according to the manufacturer’s
recommendations.
Studies
Study 1—reliability
Reliability trials of VE, VO2 and VCO2 measured by the
MM3B were examined by attaching a known CO2 gas
supply (20.62%) to the inspired port of the GESV as rec-
ommended by the manufacturer. Each trial consisted of the
GESV working at 1.0 L at low respiratory rate, 1.5 L at
medium respiratory rate, and 1.5 L at high respiratory rate,
with the GESV inspiratory/expiratory port connected
directly in-series to the MM3B turbine. Each trial was
repeated twice at each level of VE, VO2, and VCO2 in order
to assess the reliability of this measure, all during the
same day, with re-calibration of the MM3B between each
trial.
Study 2—stability
To measure the stability/drift of two components of the
MM3B (a) the gas analysers; a known gas (15.83% O2 and
4.05% CO2) was introduced to the sampling line of the
MM3B at 0, 20, 40, 60, 120 and 180 min; (b) the full
system; simulated VO2 and VCO2 were introduced by
attaching a 20.62% CO2 gas to the inspired port of the
GESV as recommended by the manufacturer. A trial
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consisted of the GESV working at 1.0 L at low respiratory
rate, 1.5 L at medium respiratory rate, and 1.5 L at high
respiratory rate, with the GESV inspiratory/expiratory port
connected directly to the MM3B turbine for 30 complete
‘‘breaths’’ at 20-min intervals until 180 min had elapsed.
The 180-min time period was considered as the maximum
period the MM3B would be used during field measures
once it had been calibrated prior to data collection.
Study 3—validity
The eight participants performed one trial comprising
stages of resting and incremental cycling exercise (Corival
400, Lode, The Netherlands). Each exercise stage lasted
13 min and measurements were made in-parallel (sequen-
tially) with the DBM, the MM3B, and an Oxycon Pro
system. The Oxycon Pro system acted as a ‘‘secondary
criterion’’ as it has been shown to be a valid metabolic
system in its mixing-chamber mode (Foss and Hallen
2005). The DBM collections of expired gas were used as
the primary criterion and the order of measurement system
followed a counterbalanced Latin-Square process so as to
avoid any order effect (Bradley 1958). The expired gas
collected by the DBM was immediately measured by the
calibrated S-3A oxygen and CD-3A carbon dioxide ana-
lyzers and then passed through the dry gas meter whose
accuracy (0.8% error) had been previously checked using
multiple pumps of a 3-L calibration syringe (Hans
Rudolph).
Each trial using the DBM, MM3B, and the Oxycon Pro
began with a 10-min rest period, with gas collection over the
final 5 min. Each participant then pedaled at a constant rate
of 50 rpm in three or four stages, starting from 50W and with
a 25W or 50W increment according to their perceived fitness
and body size. Each exercise stage lasted for a total of 13
continuous minutes. Each participant exercised for 5 min
whilst breathing into the first instrument, and then kept
pedaling at the same rate for 1 min during which the
experimenter quickly changed to the second measurement
system. As the participant was already in steady-state exer-
cise, the participant continued exercise for 3 min with the
second measurement system, and then the procedure was
repeated for the third measurement system. The three for four
intensity levels were later classified as being representative
of resting, moderate or vigorous exercise. The data used in
calculation of all variables was the mean of the final 2 min of
measurement with each device, which was considered to be
during the steady state (supported by visual inspection of the
heart rate). All trials were performed in a quiet laboratory in
environmentally stable conditions; any variations in FIO2
and FICO2 during DBM collections were noted from the
Applied Electrochemistry analysers and appropriate cor-
rections made in the DBM calculations.
Data analysis
Tests to examine any differences between the dependent
variables of VE, VO2, VCO2, FEO2, and FECO2 included
percentage differences, repeated-measures ANOVA, and
the Bland–Altman analysis (Bland and Altman 1986).
Univariate Intra-Class Correlation Coefficients (ICC), and t
tests (for shift in the mean scores) were also used in the
reliability tests between repeated measures. Technical
Errors of Measurement (TEM) were generated for both the
between-device validity comparisons (inter-TEM), as well
as within-device reliability comparisons (intra-TEM), fol-
lowing similar procedures reported by Gore et al. (2000).
SPSS (8.0) was used for most analyses, with the TEM ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
P
D2=2N
p
where D is the difference between the pairs of
measurement, and N is the number of measurement
pairs.
Results
In the reliability trials of the MM3B in measuring VE, VO2,
and VCO2 with a re-calibration in-between (Study 1), sig-
nificant but small differences were found for VO2 and
VCO2 at all levels of frequencies. As shown in Table 1, the
percentage differences between the two trials were con-
sistency less than 2.5%, whilst the average intra-device
TEM across all pumping frequencies was 0.2, 1.4 and 1.1%
for VE, VO2 and VCO2, respectively. Ideal ICC values
(r = 1.00) were also obtained by the MM3B in the repe-
ated measurements of VE, VO2, and VCO2.
The stability/drift trials of the MM3B gas analysers
(Study 2) showed that when compared to the baseline
(0 min), significant but small differences were found for
FEO2 and FECO2 at each subsequent measurement time
(20, 40, 60, 120 and 180 min). The differences ranged from
0.01 to 0.09% for FEO2 and -0.05 to -0.16% for FECO2.
Table 2 shows the descriptive statistics for the gas con-
centration in percentages and comparisons between each
time point and the baseline by the MM3B. FECO2 imme-
diately dropped nearly 4% at the first 20-min interval and
this under-measurement slowly improved until 120 min
where only a 1% difference from the baseline existed. Very
small, yet statistically significant, increases were also seen
in FEO2 as it slowly drifted upwards.
Results of the full system analysis of how VO2 and
VCO2 drifted over time (Study 2, see Table 2) showed that
at low metabolic rate, VO2 started to drift upwards from the
baseline at the 60th minute onwards and resulted in an
average of 2% difference. A significant drift of VCO2 was
found at the 20th minute and continued to deviate signifi-
cantly from the baseline at the 60th minute onwards and
this resulted in an average of 3% difference. At medium
Eur J Appl Physiol
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and high metabolic rates, some values slightly and signif-
icantly higher than the baseline VO2 were found around the
100–120 min mark. For VCO2 at medium and high meta-
bolic rates, there were few significant or consistent trends
to the drift.
The descriptive statistics for differences between the
MM3B as compared to the primary criterion (DBM) and
the secondary criterion (Oxycon Pro) are shown in
Table 3 (Study 3), whilst detailed comparisons for the
resting, moderate, and vigorous activity between the
DBM and MM3B using data from the Bland–Altman
analysis, percentage differences, as well as TEM are
shown in Table 4. The combined data for all activities are
shown in Fig. 1, where no systematic error with some
proportional random error is seen in VE, whilst both VO2
and VCO2 show evidence of both proportional systematic
and random errors (Atkinson et al. 2005). No statistically
significant differences in VE were seen between the DBM
and MM3B despite the overall TEM% averaging around
11%, and the MM3B underestimating resting VE by
nearly 9%. However, significant differences were seen in
both VO2 and VCO2 for moderate and vigorous activity,
with the MM3B overestimating these variables by more
than 10% and producing TEM% values that varied from 9
to 18%. When compared to the Oxycon Pro, the MM3B
varied significantly at all levels of VO2 and VCO2, but
only for moderate VE (Table 3). Interestingly, Table 3
also shows that when compared to the primary criterion
DBM, the secondary criterion Oxycon Pro showed no
significant differences in VE, VO2 or VCO2 at rest, mod-
erate or vigorous activity.
Discussion
This is the first study to comprehensively examine the
reliability and prolonged stability of the Cortex Metamax
3B over multiple ranges of simulated exercise conditions,
as well as performing validity comparisons against both a
primary criterion DBM, and a secondary criterion (Oxycon
Pro) over metabolic ranges suited to non-elite participants
(e.g., adolescents/elderly).
Meyer et al. (2005) reported that despite the need for
establishing the reliability of portable gas analysis devices,
few studies have addressed this issue; however, three
studies appear to have reported data on the reliability of the
Metamax 3B. The study by Perkins et al. (2004) examined
reliability of the MM3B but used repeated measurements
on human participants, which inflates the variability as it
combines the relatively large biological error of the par-
ticipants and the smaller technical error of the machine
[their contributions to the total variability has been esti-
mated to be 90% and 10% respectively (Macfarlane 2001)].
Even so, Perkins et al. (2004) reported the MM3B had
extremely high single and multiple trial reliabilities and
with narrow confidence intervals. Prieur et al. (2003)
reported data from a stability trial using a comprehensive
gas exchange simulator that showed the MM3B to be very
reliable, although data were provided for only a single
metabolic rate (VO2 = 2.6 L min
-1). Data from the Vogler
study (Vogler et al. 2010) also showed that the MM3B to
be extremely reliable, with typical errors that ranged from
2.0% (VO2) and 3.6% (VE), which were superior to the
reliability of their criterion Douglas bag system.
Table 1 Reliability results, showing the mean ± SD values, percentage differences, and intra-device TEM (%) of VE, VO2 and VCO2 (L min
-1)
of repeated trials by the MetaMax 3B across a range of low, moderate, high metabolic rates generated by the Gas Exchange System Validator
Metabolic rate Trial 1 Trial 2 % difference# Intra-device TEM (%)
VE (BTPS, L min
-1) Low 9.94 ± 0.06 9.93 ± 0.08 -0.1 0.1
Medium 29.53 ± 0.28 29.69 ± 0.23 0.5 0.4
High 58.06 ± 0.61 58.10 ± 0.65 0.1 0.0
VO2 (STPD, L min
-1) Low 0.30 ± 0.01 0.30 ± 0.00 1.9* 1.3
Medium 1.62 ± 0.01 1.65 ± 0.01 1.8* 1.3
High 2.74 ± 0.03 2.80 ± 0.03 2.3** 1.6
VCO2 (STPD, L min
-1) Low 0.29 ± 0.01 0.29 ± 0.00 2.5* 1.7
Medium 1.57 ± 0.02 1.59 ± 0.02 1.2* 0.8
High 2.66 ± 0.04 2.69 ± 0.04 1.1* 0.8
TEM% technical error of measurement expressed as a percentage of mean
# Percentage differences were calculated from mean data using four decimal places, but the data are reported here to two decimal places only
* Significant difference (p \ 0.05)
** Significant difference (p \ 0.01) from t test
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The reliability data from our study that used the GESV
to simulate a wide range of conditions likely to be expe-
rienced in normal field trials (e.g., low, medium, and high
metabolic rates), showed that the technical variability of
the MM3B measurements was adequately low. The relative
percentage errors for VE, VO2 and VCO2 all being typically
less than 2% between tests, with the TEM% generally less
than 1.5%. These reliability results compare favorably with
a 1% relative error generated from a complex automated
calibration system (Gore et al. 1997), and is below the
TEM reliability limit of 3% as recommended by the Aus-
tralian Sports Commission (Gore 2000) for these variables.
An important aim of this study was to examine the
stability (or resistance to drift) of key variables measured
by the MM3B (gas fractions, VO2, VCO2) over a 3-h period
that would reflect the longest likely time the MM3B would
be used in the field after calibration in the lab (e.g., 60 min
travel time to destination, 30 min preparation on-site, then
allowing up to 90 min of episodic data collection). In
countries like Hong Kong, where some field measures are
undertaken in remote locations with no parking for private
vehicles, it is often not feasible to transport calibration
equipment to the site, necessitating prior calibration in the
lab and reliance that the equipment is adequately stable
over time. Our analysis, although limited to static labora-
tory conditions, therefore partially addresses the comment
by Atkinson et al. (2005) that insufficient data is available
on how stable specific gas analysis systems are, as does the
paper by Eriksson et al. (2011).
The results of this study agrees with that of Prieur et al.
(2003) that the MM3B shows some statistically significant
drift, however, the absolute magnitude of this drift is small.
The relative errors appear to be large (2–3%) only when the
comparative original value is small (i.e., low denominator
in the resting conditions), but under typical moderate-to-
vigorous exercise conditions, the absolute error is relatively
minor and is seen more in VCO2 and likely due to a greater
drift in the FECO2 measurement. As these drifts in VO2 and
Table 3 Validity results,
showing the mean ± SD values
of physiological variables
measured by the three metabolic
systems during parallel data
collection at rest, moderate, and
vigorous cycle exercise
* Significantly different to
Douglas bag measurements
(ANOVA, p \ 0.05)
^ Significantly different to
Oxycon Pro measurements
(ANOVA, p \ 0.05)
Activity Douglas bag MetaMax 3B Oxycon Pro
VE (BTPS, L min
-1) Rest 8.72 ± 1.03 7.93 ± 1.73 7.72 ± 1.82
Moderate 29.89 ± 8.19 30.61 ± 9.78^ 28.73 ± 8.31
Vigorous 66.00 ± 20.52 66.25 ± 19.16 62.54 ± 18.26
VO2 (STPD, L min
-1) Rest 0.27 ± 0.04 0.30 ± 0.08^ 0.25 ± 0.06
Moderate 1.12 ± 0.33 1.24 ± 0.41*^ 1.12 ± 0.36
Vigorous 2.32 ± 0.46 2.59 ± 0.52*^ 2.37 ± 0.44
VCO2 (STPD, L min
-1) Rest 0.22 ± 0.04 0.26 ± 0.07^ 0.20 ± 0.06
Moderate 1.03 ± 0.31 1.17 ± 0.40*^ 1.01 ± 0.33
Vigorous 2.25 ± 0.52 2.64 ± 0.66*^ 2.17 ± 0.43
Table 4 Validity analyses of the Metamax 3B data against the Douglas bag (primary criterion) during parallel data collection at rest, moderate,
and vigorous cycle exercise
Variable Activity level Bland–Altman bias (L min-1) % difference Inter-device TEM (%)
Mean ± SD (95% LOA) Mean ± SD Mean
VE (BTPS, L min
-1) Rest -0.79 ± 1.62 (2.45, -4.04) -8.8 ± 19.3 17.0
Moderate 0.72 ± 2.76 (6.24, -4.80) 1.5 ± 9.8 7.0
Vigorous 0.25 ± 10.02 (20.28, -19.79) 2.2 ± 13.3 9.7
VO2 (STPD, L min
-1) Rest 0.03 ± 0.05 (0.14, -0.07) 10.6 ± 19.3 14.0
Moderate 0.12 ± 0.14** (0.41, -0.16) 9.7 ± 13.2** 10.9
Vigorous 0.27 ± 0.16** (0.59, -0.05) 11.8 ± 7.6** 9.4
VCO2 (STPD, L min
-1) Rest 0.04 ± 0.05 (0.14, -0.06) 17.3 ± 21.8 18.0
Moderate 0.14 ± 0.11** (0.36, -0.08) 12.5 ± 9.8** 10.6
Vigorous 0.39 ± 0.23** (0.85, -0.07) 17.4 ± 8.1** 12.8
Data shown from Bland–Altman analyses (mean ± SD of bias, and 95% limits of agreement, LOA), percentage differences between means, and
the inter-device TEM (%)
Bias and differences computed for data calculated from the Metamax 3B–Douglas bag
TEM% technical error of measurement expressed as percentage of mean value
** Metamax 3B significantly different to Douglas bag measurements (ANOVA, p \ 0.01)
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VCO2 during simulated intermittent exercise lasting
180 min were all below 2%, there are unlikely to be of
physiological importance, to the extent that the MM3B can
be considered very stable.
During moderate and vigorous exercise the MM3B
significantly overestimated VO2 and VCO2, but not VE, by
10–17% when compared to the primary criterion DBM,
but at all VO2 and VCO2 values during exercise when
compared to the secondary criterion Oxycon Pro. In com-
parison, there were no significant differences in VO2, VCO2
or VE across all conditions between the primary (DBM) and
secondary (Oxycon) criterion machines, which support a
previous study showing the Oxycon Pro’s mixing-chamber
mode to be very accurate (Foss and Hallen 2005). How-
ever, for the key VO2 variable, previous validation studies
on the MM3B have produced inconsistent findings, with
both overestimates (Perkins et al. 2004; Vogler et al. 2010)
and underestimates (Brehm et al. 2004; Laurent et al. 2008;
Prieur et al. 2003) being reported. The relatively large
percentage errors reported in our study for VO2 and VE by
the MM3B are generally higher than those reported in the
above validation studies, and also exceed the 4–10%
guidelines recommended by some (Brehm et al. 2004;
Laurent et al. 2008; Vogler et al. 2010), although these
limits are not universally agreed upon (Macfarlane 2001).
It is worth noting that some percentage differences (in the
means) between the MM3B and DBM in Table 4 were
relatively small (e.g., VE during moderate and vigorous
exercise,\2.5%), yet were associated with relatively large
TEM% scores of [7%. This was possibly due to large
(quasi-symmetric) variation in the pairs of data around the
mean, as the TEM% is sensitive to the degree of variability
in the data pairs (and systematic error), yet this variability
is not reflected in the percentage difference of the mean
scores as it is only sensitive to systematic error.
It is unclear why our relative errors in VO2 and VCO2
are higher than other MM3B validation studies, as it is
unlikely this was due to errors made in the Douglas bag
assessments, as there was good agreement between the
primary DBM and secondary Oxycon Pro criterions. Nor
was greater variation likely to be due to our small number
of participants (n = 8), as other validation studies have
also used comparable numbers (n = 8–11) of participants
(Brehm et al. 2004; Laurent et al. 2008; Prieur et al. 2003;
Vogler et al. 2010). The slow drift upwards in VO2 and
VCO2 over time by\4% at a low metabolic rate and\2%
at the two higher metabolic rates, as reported in Table 2,
may partially account for some, but not all, of the error. It
would appear that the additional challenges of measure-
ment during dynamic human exercise, such as movement
shocks, gas leakages, saliva entrapment, and variations in
gas and flow waves as suggested by Prieur et al. (2003),
might incur greater measurement errors that are not seen
during static testing using a mechanical simulator.
This study contains several limitations. Ideally, valida-
tions should be done using a serial method so that all
expired gases passes sequentially through the MM3B and
then into the Douglas bag; however, as outlined by others
(Prieur et al. 2003; Vogler et al. 2010), and confirmed in
our lab, this was not possible due to interference during
simultaneous measurements, and instead we used separate
Fig. 1 Modified Bland–Altman plots showing agreement between
measurements taken across all activities combined (rest, moderate,
vigorous) for all eight subjects from the Metamax 3B (MM3B) and
criterion Douglas bag method (DBM). Y axes showing the absolute
differences in VE (BTPS), VO2 (STPD) and VCO2 (STPD) plotted
against the average values of both methods (X axes)
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(parallel) trials. The stability/drift analysis was performed
only under stable laboratory conditions and without the
device being subjected to regular movements and envi-
ronmental changes as might occur during transport out-
doors to a remote venue. It is unknown how changing
environmental conditions might influence the validity and
reliability of the MM3B. As we were interested in evalu-
ating the MM3B for prolonged field studies on children, the
participants we recruited for the validation phase of this
study were not highly trained athletes, hence the upper
range of their metabolic responses even during vigorous
exercise are unlikely to be cover the range necessary to
study elite athletes.
Summary
In many situations the MM3B will be used in field studies
and when used at remote sites the results of this study
suggest this device remains acceptably stable (significant
variations were of minor physiological importance) for
periods up to 3 h. The MM3B is also very reliable, but
appears to be insufficiently valid when measuring VO2 and
VCO2 during moderate and high intensities (evidence of
proportional systematic and random errors), although these
errors may be mitigated using a simple linear regression
equation.
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